BCDA Stock Analysis: Buy, Sell, or Hold?
BCDA - BioCardia, Inc. Common Stock
$1.00
0.03 (3.43%)
▲
5d:
+20.03%
30d:
+9.69%
90d:
-16.67%
BUY
HIGH Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 10, 2026
Get Alerted When BCDA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: BCDA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
✅ BUY SIGNAL: BCDA shows strong fundamentals and good volume confirmation. Solid entry point despite slightly high pricing.
In-depth Analysis How we analyze
Valuation Analysis: BCDA is currently trading at $1.00, which is considered slightly high relative to its 30-day fair value range of $0.86 to $0.98.
Technical Outlook: Technically, BCDA is in a strong downtrend. Immediate support is located at $0.78, while resistance sits at $1.03. The stock is showing strong short-term momentum, up 3.4% recently.
Market Sentiment: BCDA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $15.50 (+1450.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BCDA is in a strong downtrend. Immediate support is located at $0.78, while resistance sits at $1.03. The stock is showing strong short-term momentum, up 3.4% recently.
Market Sentiment: BCDA has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $15.50 (+1450.0%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.86 -
$0.98
Company Quality Score
54/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
78.9%
All Signals
- BULLISH: Strong technical setup (60/100)
- BULLISH: Strong upward momentum (+3.4%)
- BULLISH: Trading 1450.0% below Wall St target ($15.50)
Trading Range Analysis
30-Day Trading Range
$0.86 -
$0.98
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$0.78
Resistance Level
$1.03
Current Trend
Strong Downtrend
Technical data as of
Jun 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.67
Wall Street Target
$15.50
(+1450.0%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: June 23, 2026 9:32 PM ET
Data refreshes hourly during market hours. Next update: 10:32 PM
Data refreshes hourly during market hours. Next update: 10:32 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BCDA showing a specific setup today?
Insider Activity (6 Months)
5
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Peter Altman
BUY
400 shares
2026-04-21
Peter Altman
BUY
600 shares
2026-04-20
Peter Altman
BUY
5000 shares
2026-02-04
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1022 | 67 BUY |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$197 | 61 BUY |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 57 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
14 analysts |
$105 | 57 HOLD |